European Circular Bioeconomy Fund (ECBF)’s Post

📢 𝗥𝗼𝗮𝗱𝘀𝗵𝗼𝘄 𝗦𝗲𝗿𝗶𝗲𝘀 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: 𝗧𝗵𝗲 𝗡𝗲𝘁𝗵𝗲𝗿𝗹𝗮𝗻𝗱𝘀 🚙   📍 Where? Delft & Amsterdam, NL 📅 When? 24th - 25th April   We're excited to announce our upcoming roadshow, which aims to catalyse the #biobased circular economy in the Netherlands! A big shout out to the Dutch ecosystem, which has seamlessly combined government support, business acumen and research brilliance to drive bio-economic innovation.   Join us as we connect with investors and pioneering companies at the forefront of industrial biotechnology. This two-day trip will be an incredible opportunity to dive into innovations in #fermentation, #biorefineries, #biocatalysts and technologies that improve our everyday lives.   We're looking forward to meeting Daan Meijer in Amsterdam. He's our contact at our limited partner and valuable co-investor Invest-NL, a key Dutch investment company focused on supporting economic growth by financing sustainable and socially responsible ventures, playing a crucial role in the Netherlands' transition to a greener and more innovative economy. Ditto Bouke de Jong from Planet B.io, a hub within the vibrant biotech ecosystem of Biotech Campus Delft. One of Europe's largest open innovation campuses dedicated to #biotech.   Delft and Amsterdam - both hotspots for circular economy innovation, supported by strong market potential and a vibrant venture ecosystem. TU Delft's reputation as a leader in circular economy further underlines the region's suitability for our roadshow.   Our Industrial Biotech team Jowita Sewerska, CFA, Jisk de Vries and Bernadette Lee look forward to meeting you in the Netherlands.   Are you also interested in meeting the ECBF? Then get in touch with Bernadette Lee and let's arrange a meeting either in Amsterdam or Delft.   Let's move the biotech sector forward together! 🌱   #Sustainability #Innovation #Biotech #CircularEconomy

  • graphical user interface, website
Daan van Oldeniel

Business Developer @ Campus Groningen & LIFE Cooperative LifeSciences | Innovation | Medtech | Pharma | Biotech

8mo

To view or add a comment, sign in

Explore topics